Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) - Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first discovered in 2012 in a patient who died from severe respiratory disease. Since then, and as of 16 January 2020, 2 521 cases have been reported worldwide, including 919 deaths (crude case fatality 36%). Most cases have been reported from the Arabian Peninsula (and around 84% specifically from Saudi Arabia), and all cases elsewhere had a travel history to the Arabian Peninsula or were a contact of someone who had a travel history to the region.
Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus as the causative agent of this outbreak, coronavirus disease 2019 (COVID-19).
Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – eighth update
Since 31 December 2019 and as of 7 April 2020, over 1.3 million (1 316 988) cases of COVID-19 have been reported worldwide, and more than 70 000 (74 066) deaths. Half of these cases (608 500) have been reported from the EU/EEA countries and the UK, and over 50 000 (51 059) of them have died.
Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK– ninth update
Since 31 December 2019 and as of 22 April 2020, approximately 2.5 million (2 524 812) cases of COVID-19 have been reported worldwide and 177 780 deaths. Of these, 988 241 cases were reported by EU/EEA countries and the UK, including 105 064 deaths.
Projected baselines of COVID-19 in the EU/EEA and the UK for assessing the impact of de-escalation of measures
This report aims to provide a short-term 30-day forecast of the expected number of COVID-19 cases, deaths and hospitalised cases (including general hospital ward and intensive care unit) under a set of assumptions.
Mobile applications in support of contact tracing for COVID-19 - A guidance for EU EEA Member States
This document is intended to facilitate the dialogue between public health authorities and app developers to ensure that the main epidemiological and operational considerations are taken into account, while also understanding the technological limitations.
Guidance on infection prevention and control of COVID-19 in migrant and refugee reception and detention centres in the EU/EEA and the UK
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK).
Monitoring and evaluation framework for COVID-19 response activities in the EU/EEA and the UK
The purpose of this monitoring and evaluation framework is to support EU and EEA countries and the UK in their efforts to monitor the implementation and effects of COVID-19 response activities. The framework presents indicators for a variety of key pillars of COVID-19 preparedness, prevention and control activities and provides guidance to countries on how to collect and analyse data for the suggested indicators. The strategic information provided by the indicators can assist decision makers at subnational, national and EU level to support preparedness and response planning, and in-action and after-action reviews. The framework will need to be adapted to local circumstances; the relevance of indicators depends on the specificities of the setting.
Heating, ventilation and air-conditioning systems in the context of COVID-19
The scope of this document is to provide guidance on ventilation of indoor spaces in the context of COVID-19.